Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2026
Option Care Health reported Q3 2026 revenue of $1.49B, up 4.1% YoY, with GAAP net income of $57.4M, up 10.8%. The company is being acquired by Clayton, Dubilier & Rice and McKesson, leading to withdrawn financial guidance. Key metrics include adjusted EBITDA of $124.6M and adjusted EPS of $0.49.
How this was made
The 30-second read
Why it matters
The Q3 earnings release provides fresh financial metrics and confirms the pending merger, offering traders actionable data.
Market read
First-report Q3 earnings for OPCH with modest growth and an acquisition pending, offering a clear trading catalyst.
What to watch
Potential integration costs and regulatory approvals for the pending merger.
Background
Option Care Health is the largest independent provider of home and alternate site infusion services in the US.
Ticker impact
Option Care Health reported Q3 2026 results with revenue of $1.493.5M (up 4.1%) and GAAP EPS of $0.38 (up 18.8%).
potential modest upside as earnings exceed expectations, though acquisition uncertainty may cap gains
New earnings numbers are better than prior period and provide fresh data for traders; acquisition news adds a risk factor.
Market effects
Highlights strength in home infusion services sector and may influence peers' valuations.
US healthcare services market sees a positive data point.
Limited to US-listed healthcare investors.
Counterpoint
Acquisition uncertainty could depress the stock despite earnings beat.
Key entities
- companyOption Care Health
US-listed provider of home infusion services (ticker OPCH).
- private equity firmClayton, Dubilier & Rice
Acquirer in the pending merger with Option Care Health.
- companyMcKesson Corporation
Acquirer in the pending merger with Option Care Health.
